• Monitoring responses to anti-TNF treatments

    Theradiag are developing their “Lisa-Tracker” test for monitoring how well Crohn’s disease patients respond to anti-TNF treatments. Because these treatments are so expensive, rationalising their use (to people who will respond and at the right doses in those that do) will be become increasingly important.

    To read the full article click here.